menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Hybrid Model for Contraceptive Care in Private Practice

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

How can you incorporate a hybrid model for contraceptive care into your practice? An OB/GYN shares his approach and experience.

  • Sponsored by

  • Overview

    The COVID-19 pandemic impacted the way contraceptive care was offered to patients, with many offices turning to telemedicine.1 Telemedicine can be used while still offering long-acting reversible contraception (LARC) options by implementing a hybrid model for care.2,3 This type of approach consists first of a telemedicine appointment to counsel patients on all appropriate contraceptive options and, if necessary, an in-person appointment to initiate any contraceptive method that requires placement by a healthcare provider.2,3 To learn more about how you can incorporate this model into your practice, tune in to hear Dr. Edmund Kim share his approach and how the use of a hybrid model has enabled him to continue to offer all contraceptive options, including LARCs.2-4

    References:
    1. Comfort AB, Rao L, Goodman S, et al. Assessing differences in contraceptive provision through telemedicine among reproductive health providers during the COVID-19 pandemic in the United States. Reprod Health. 2022;19(1):99.

    2. Stifani BM, Madden T, Micks E, et al. Society of Family Planning clinical recommendations: contraceptive care in the context of pandemic response. Contraception. 2022;113:1–12.

    3. Prioritization of in-person and virtual visits during COVID-19: a decision-making guide for staff. Family Planning National Training Center. Accessed December 15, 2022. 
    https://rhntc.org/sites/default/files/resources/fpntc_priority_decision_guide_2020-04-29.pdf

    4. Gavin L, Moskosky S. Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep. 2014;63(4):1–54.

    © 2023 Organon group of companies. All rights reserved.
    ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.
    US-XPL-116647 03/23

Schedule3 Mar 2024